Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:1885-1891

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bachmaier, K.
Right arrow Articles by Penninger, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bachmaier, K.
Right arrow Articles by Penninger, J. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Autoimmune Diseases
*Cardiomyopathy
Hazardous Substances DB
*L-TYROSINE
Related Collections
Right arrow Animal models of human disease
Right arrow Genetically altered mice
Right arrow Myocardial cardiomyopathy disease

(Circulation. 1999;99:1885-1891.)
© 1999 American Heart Association, Inc.


Basic Science Reports

Generation of Humanized Mice Susceptible to Peptide-Induced Inflammatory Heart Disease

Kurt Bachmaier, MD, ; Nikolaus Neu, MD, ; Rae S. M. Yeung, MD, ; Tak W. Mak, PhD, ; Peter Liu, MD, ; Josef M. Penninger, MD,

From Amgen Institute, Ontario Cancer Institute, and the Departments of Medical Biophysics and Immunology, University of Toronto, Ontario, Canada (K.B., R.S.M.Y., T.W.M., J.M.P.); The Toronto Hospital, Ontario, Canada (K.B., P.L.); and the Department of Pediatrics, University of Innsbruck, Austria (N.N.).

Correspondence to Dr J.M. Penninger, Amgen Institute, 620 University Ave, Suite 706, Toronto, Ontario, Canada M5G 2C1. E-mail Jpenning{at}amgen.com

Background-Dilated cardiomyopathy (DCM) is a major cause of sudden cardiac death. In certain mouse major histocompatibility complex (MHC) backgrounds, myocarditis and inflammatory cardiomyopathy can be triggered by immunization with heart muscle–specific proteins. Similarly, chronic heart disease in humans has been linked to certain HLA alleles, such as HLA-DQ6. However, there is no experimental evidence showing that human MHC class II molecules and peptides derived from human proteins are involved in the pathogenesis of myocarditis and DCM.

Methods and Results—We generated double CD4- and CD8-deficient mice transgenic for human CD4 (hCD4) and human HLA-DQ6 to specifically reconstitute the human CD4/DQ6 arm of the immune system in mice. Transgenic hCD4 and HLA-DQ6 expression rendered genetically resistant C57BL/6 mice susceptible to the induction of autoimmune myocarditis induced by immunization with cardiac myosin. Moreover, we identified heart-specific peptides derived from both mouse and human {alpha}-myosin heavy chains capable of inducing inflammatory heart disease in hCD4 and HLA-DQ6 double transgenic mice but not in hCD4 single transgenic littermates. The autoimmune inflammatory heart disease induced by the human heart muscle–specific peptide in hCD4 and HLA-DQ6 double transgenic mice shared functional and phenotypic features with the disease occurring in disease-susceptible nontransgenic mice.

Conclusions—Our data provide the first genetic and functional evidence that human MHC class II molecules and a human {alpha}-myosin heavy chain–derived peptide can cause inflammatory heart disease and suggest that human inflammatory cardiomyopathy can be caused by organ-specific autoimmunity. The humanized mice generated in this study will be an ideal animal model to further elucidate the pathogenesis of inflammatory heart disease and facilitate the development of rational treatment strategies.


Key Words: cardiomyopathy • molecular biology • myocarditis • genes




This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. Li, J. S. Heuser, S. D. Kosanke, M. Hemric, and M. W. Cunningham
Cryptic Epitope Identified in Rat and Human Cardiac Myosin S2 Region Induces Myocarditis in the Lewis Rat
J. Immunol., March 1, 2004; 172(5): 3225 - 3234.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. F. Elliott, J. Liu, Z.-N. Yuan, N. Bautista-Lopez, S. L. Wallbank, K. Suzuki, D. Rayner, P. Nation, M. A. Robertson, G. Liu, et al.
Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IA{beta} knockout NOD mice
PNAS, November 11, 2003; 100(23): 13447 - 13452.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. P. Liu, J. Le, and M. Nian
Nuclear Factor-{kappa}B Decoy: Infiltrating the Heart of the Matter in Inflammatory Heart Disease
Circ. Res., November 9, 2001; 89(10): 850 - 852.
[Full Text] [PDF]


Home page
HeartHome page
H SONG, H TASAKI, A YASHIRO, K YAMASHITA, T TOYOKAWA, Y NAGAI, H TAKATSU, H TANIGUCHI, and Y NAKASHIMA
Dilated cardiomyopathy and Chlamydia pneumoniae infection
Heart, October 1, 2001; 86(4): 456 - 458.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Kishimoto, N. Takamatsu, H. Kawamata, H. Shinohara, and H. Ochiai
Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix change
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1979 - 1984.
[Abstract] [Full Text] [PDF]